Ongoing presence of Leishmania major cutaneous leishmaniasis in Mauritania, 2016–2024
The study confirms the ongoing presence of CL in Mauritania, particularly in the southern areas and provides confirmation of the presence of L. major. It underscores the urgent need to locally develop appropriate diagnostic tools and to authorize the commercialization of meglumine antimoniate in the country. Further studies should be conducted to better determine the disease burden, identify vectors and reservoirs and evaluate therapeutic options.
Authors
- M Kébé
- Magalie Demar (ORCID: https://orcid.org/0000-0003-3414-0821)
- Mamadou Fofana
- Mona Saout
- Mohamed Ouldabdallahi Moukah (ORCID: https://orcid.org/0000-0002-8247-9750)
- Ali Ould Mohamed Salem Boukhary (ORCID: https://orcid.org/0000-0001-7317-2776)
- Romain Blaizot (ORCID: https://orcid.org/0000-0003-3695-6824)
- Mahamadou A. Théra (ORCID: https://orcid.org/0000-0002-2679-035X)
- Abdoulaye K. Koné (ORCID: https://orcid.org/0000-0003-4101-5391)
- Aminetou El Moctar
- Taleb Khyar Cheikh Mohamed Vadel
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- University of French Guiana (GF)
- Institut National de Recherche en Santé Publique (ML)
- Center for Infection and Immunity of Lille (FR)
- Institut Pasteur de la Guyane (GF)
- Université des Sciences, des Techniques et des Technologies de Bamako (ML)
- Centre Hospitalier Andrée Rosemon (GF)
- Université des Sciences, de Technologie et de Médecine (MR)
- Université de Nouakchott (MR)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1186/s12879-025-10716-w
- Primary Topic
- Research on Leishmaniasis Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00